15012456311
當前位置：深圳遠揚化學技術有限公司>>技術文章>>奧格列汀雜質 奧格列汀異構體對照品
奧格列汀市場前景：奧格列汀為超長效二肽基肽酶-4(DPP-4)抑制劑，其作用機制是通過抑制體內DPP-4酶對胰高血糖素樣肽-1（GLP-1）的降解作用，延長GLP-1的作用時間，從而提高血液中內源性GLP-1和GIP的濃度，并zui終改善血糖控制。2013年抗糖尿病治療藥物銷售額達到了469億美元的市場規模 ，其中DPP-4抑制劑銷售市場達到93.88億美元，同比上一年增長了10.24%，是快速發展的一類藥物。
深圳遠揚化學可提供奧格列汀申報所用全套雜質， 隨貨附CoA證書，HNMR，MS，HPLC圖譜，純度符合申報要求，歡迎我司（何 ；phastandards； ）。請點擊本頁標題下方“進入該公司展臺” 查看我司信息。
| MK-3102 | (2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)tetrahydro-2H-pyran-3-amine |
| MK-3102 Impurity 1 | tert-butyl ((2S,3S)-2-(2,5-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl)carbamate |
| MK-3102 Impurity 2 | tert-butyl ((2S,3R)-2-(2,5-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl)carbamate |
| MK-3102 Impurity 3 | tert-butyl ((2R,3R)-2-(2,5-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl)carbamate compound with tert-butyl ((2S,3S)-2-(2,5-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl)carbamate (1:1) |
| MK-3102 Impurity 4 | tert-butyl ((2R,3S)-2-(2,3-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl)carbamate |
| MK-3102 Impurity 5 | tert-butyl ((2R,3S)-2-(3,4-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl)carbamate |
| MK-3102 Impurity 6 | 1-(methylsulfonyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole |
| MK-3102 Impurity 7 | S,5R)-2-(2,5-difluorophenyl)-5-(1-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(1H,4H,6H)-yl)tetrahydro-2H-pyran-3-amine |
| MK-3102 Impurity 8 | (2R,3S,5S)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)tetrahydro-2H-pyran-3-amine |
| MK-3102 Impurity 9 | (2S,3S,5S)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)tetrahydro-2H-pyran-3-amine |
| MK-3102 Impurity 10 | (2S,3S,5R)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)tetrahydro-2H-pyran-3-amine |
| MK-3102 Impurity 11 | (2S,3R,5S)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)tetrahydro-2H-pyran-3-amine |
| MK-3102 Impurity 12 | (2R,3R,5R)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)tetrahydro-2H-pyran-3-amine |
| MK-3102 Impurity 13 | (2S,3R,5R)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)tetrahydro-2H-pyran-3-amine |
| MK-3102 Impurity 14 | (2R,3R,5S)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)tetrahydro-2H-pyran-3-amine |
| MK-3102 Impurity 15 | (2R,3S,5R)-2-(2,5-difluorophenyl)-5-(pyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)tetrahydro-2H-pyran-3-amine |
| MK-3102 Impurity 16 | (R)-5-((3R,5S,6R)-5-amino-6-(2,5-difluorophenyl)tetrahydro-2H-pyran-3-yl)-2-(methylsulfonyl)-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole 5-oxide |
| MK-3102 Impurity 17 | N-((2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)tetrahydro-2H-pyran-3-yl)acetamide |
| MK-3102 Impurity 18 | N-((2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)tetrahydro-2H-pyran-3-yl)benzenesulfonamide |
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業自行提供，信息內容的真實性、準確性和合法性由相關企業負責，化工儀器網對此不承擔任何保證責任。
溫馨提示：為規避購買風險，建議您在購買產品前務必確認供應商資質及產品質量。
